Adverse event totals18

The totals the trial posted for each group.

1 to 18 of 18

Total	Group	Affected	At risk
Total, all-cause mortality	Overall	5	49
Total, all-cause mortality	Axitinib 2 mg	1	7
Total, all-cause mortality	Axitinib 3 mg	1	9
Total, all-cause mortality	Axitinib 5 mg	3	20
Total, all-cause mortality	Axitinib 7 mg	0	2
Total, all-cause mortality	Other	0	11
Total, other adverse events	Overall	48	49
Total, other adverse events	Axitinib 2 mg	7	7
Total, other adverse events	Axitinib 3 mg	9	9
Total, other adverse events	Axitinib 5 mg	19	20
Total, other adverse events	Axitinib 7 mg	2	2
Total, other adverse events	Other	11	11
Total, serious adverse events	Overall	21	49
Total, serious adverse events	Axitinib 2 mg	4	7
Total, serious adverse events	Axitinib 3 mg	8	9
Total, serious adverse events	Axitinib 5 mg	5	20
Total, serious adverse events	Axitinib 7 mg	0	2
Total, serious adverse events	Other	4	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00828919/event-totals